Contribution of surgical oncology to the surgical volume of tertiary hospitals in Benin Authors: Freddy Houéhanou Rodrigue Gnangnon, Houénoudé Mickaël Arnaud Assogba, Kpêdétin Marie José Vianney Zannou, Roland Goudou, Salwa Fidélia Joanita Djohou, Moufalilou Aboubakar, Sètondji Gilles Roger Attolou, René Hounsou, Ismail Lawani, Dansou Gaspard Gbessi Published: 2025 ABSTRACT BackgroundCancer burden is rising in sub-Saharan Africa, where late presentation is common. Surgical oncology is pivotal for diagnosis, curative-intent management, and palliation, yet its contribution to hospital surgical activity in Benin remains undocumented.ObjectiveThis study aimed to assess the contribution of surgical oncology to the overall surgical workload in tertiary hospitals in the Littoral Department of Benin and to describe the epidemiological profile, case distribution, and early outcomes of operated patients.MethodsWe conducted a retrospective, hospital-based cross-sectional study across three tertiary referral hospitals. Retrospective data were extracted from operative logs, anesthesia records, and surgical ward files for all surgical procedures performed from January 1 to December 31, 2023.Cancer-related operations were identified and analyzed. Descriptive statistics were used to summarize the characteristics of the patients and surgeries performed. Additionally, 30-day postoperative survival was estimated using Kaplan–Meier methods.ResultsOf the 7,902 surgical procedures performed in 2023, 155 were cancer-related, accounting for 1.96% of the overall surgical volume. The most common cancer sites were breast (n = 36; 23.2%), prostate (n = 24; 15.5%), stomach (n = 16; 10.3%), colon (n = 16; 10.3%), and rectum (n = 10; 6.5%). Most patients presented with advanced disease, with 53.5% diagnosed at stage III–IV (stage III: n = 47; 30.3%; stage IV: n = 36; 23.2%). Open surgery was the predominant surgical approach (n = 125; 80.6%). Postoperative complications occurred in 23 patients (19.7% of the 117 patients with available data). Among the 114 patients with follow-up data suitable for survival analysis, seven patients had died, corresponding to a crude postoperative mortality rate of 6.1% (n = 7). At 30 days postoperatively, the estimated 30-day survival probability was 94% (95% CI: 89–99%).ConclusionIn 2023, oncologic surgeries represented a small fraction of surgical operations performed in the three tertiary hospitals located in the Littoral Department of Benin. Most surgical cases corresponded to advanced-stage tumors, reflecting the severity of disease among patients reaching surgical management.Supplementary InformationThe online version contains supplementary material available at 10.1186/s12957-025-04147-9. Introduction Cancer is one of the leading causes of death worldwide, posing a significant burden on healthcare systems and communities. Globally, an estimated 20.9 million new cancer cases and 9.7 million cancer-related deaths occurred in 2022 [1]. In Africa alone, approximately 1.4 million new cases and 850,000 deaths were recorded that same year. Surgery plays a critical role in the diagnosis, curative-intent management, and palliation of cancer, and up to 80% of patients with malignancies are estimated to require a surgical procedure at some point during their disease trajectory [2]. The complexity of oncologic surgical care complicates the rapid expansion of services in LMICs, even as surgical needs continue to grow [2]. Recently, The Lancet Commission on Global Cancer Surgery estimated that by 2030, 40 million cancer surgeries will be needed annually, with the majority of patients living in LMICs. In fact, the global need for cancer-related surgical procedures is expected to rise by an additional 5 million between 2018 and 2040 [3]. Without substantial improvements in surgical oncology capacity, countries like Benin are projected to forfeit between 0.5% and 1.5% of their annual gross domestic product from 2015 to 2030 [3]. It is therefore imperative to prepare for the cancer epidemic expected to impact the country. With nearly 7,500 new cases and over 5,000 cancer-related deaths in 2022, cancer represents a major public health challenge in Benin, a country of 14 million inhabitants in west Africa [4]. This burden is expected to grow significantly, with projections indicating that cancer incidence will double in African countries like Benin by 2040 [5]. However, despite its importance, there is no information on the delivery of surgical oncology services in the country. In LMICs such as Benin, surgical oncology services are often under-resourced and only available at the tertiary level [2]. As shown by the Tanzanian study by Brand et al. [2], mapping the surgical oncology landscape is critical for pinpointing centers of excellence where local training can be developed and for encouraging facilities to prioritize cancer surgery. To date, no study has evaluated the delivery of surgical oncology services in Benin, and data from the broader sub-Saharan African region remain scarce. This study aimed to assess the contribution of surgical oncology to the overall surgical workload in tertiary hospitals in the Littoral Department of Benin and to describe the epidemiological profile, case distribution, and early outcomes of operated patients. Materials and methods Study design and setting This was a hospital-based retrospective cross-sectional study conducted in the Littoral Department of Benin, West Africa. The Littoral Department, encompassing the city of Cotonou, the economic capital of Benin, is the smallest of the country’s twelve administrative departments, with a surface area of 79 km². Unlike other departments, it comprises a single municipality (Cotonou), subdivided into 13 districts and 140 neighborhoods. The population of the Littoral Department is projected to reach 778,885 in 2025, based on data from the fifth General Census of Population and Housing (RGPH5) and demographic projections [6]. The healthcare system in Benin is organized in a pyramidal structure, with university hospitals positioned at the apex as the main referral centers for cancer management [7]. In most instances, patients are responsible for covering the costs associated with diagnosis and treatment, though limited governmental support may be available in certain cases. Radiotherapy services are not available within the country, and the number of trained oncologists remains very limited [8]. The country lacks dedicated cancer treatment facilities. : The study was conducted in the surgical units of the three tertiary-level hospitals located in the Littoral Department of Benin, all of which have the capacity to deliver surgical oncology services: The Hubert Koutoukou Maga National University Hospital Center (CNHU-HKM).The Lagune Mother and Child University Hospital Center (CHU-MEL).The Suru Léré Regional University Hospital Center (CHUZ Suru Léré). The Hubert Koutoukou Maga National University Hospital Center (CNHU-HKM). The Hubert Koutoukou Maga National University Hospital Center (CNHU-HKM). The Lagune Mother and Child University Hospital Center (CHU-MEL). The Lagune Mother and Child University Hospital Center (CHU-MEL). The Suru Léré Regional University Hospital Center (CHUZ Suru Léré). The Suru Léré Regional University Hospital Center (CHUZ Suru Léré). These hospitals represent the major referral surgical centers not only in the south of the country but also at a nationwide level and manage a significant proportion of the cancer-related surgical workload in the country [9]. Figure 1 presents a map of the Littoral Department in Benin, highlighting the locations of the tertiary hospitals that were included in this study. Fig. 1The map showing the location of tertiary hospitals included in the study in the Littoral Department, Benin. (Data source: Google Earth; map oriented with North at the top. Hospital locations are represented by red dots.) The map showing the location of tertiary hospitals included in the study in the Littoral Department, Benin. (Data source: Google Earth; map oriented with North at the top. Hospital locations are represented by red dots.) Data collection Retrospective data were extracted from operative logs, anesthesia records, and surgical ward files for all surgical procedures performed from January 1 to December 31, 2023. For the purpose of this study, cancer surgeries were defined as any operative procedures performed with diagnostic, curative, or palliative intent for a histologically confirmed or clinically suspected malignancy [10]. Each operation was treated as a distinct observation whenever it contributed to the management of a malignant disease, including diagnostic, curative, palliative, or repeat procedures. Patients were identified through surgical unit admission logs and operating room registries based on confirmed or suspected cancer-related procedures. Additional information was obtained from medical records, intensive care unit logs, and hospitalization registers. Cross-checking across these data sources ensured consistency and prevented omission of relevant cases. Performance status was estimated using the ECOG (Eastern Cooperative Oncology Group) performance status (PS). The ECOG Performance Status also called WHO (World Health Organization) Performance Status is an assessment of the patients’ actual level of function and capability of self-care [11]. Cancer cases were staged according to the UICC-TNM (Union for International Cancer Control- Tumor, Node, Metastasis) classification and the AJCC (American Joint Committee on Cancer) classification based on the data obtained from the medical records [12]. The surgery outcome included three modalities: death, survival and loss to follow-up. The cutoff date was January 30, 2024. Cases with missing or unspecified information were retained in the analysis and reported as ‘not specified’ to provide a comprehensive overview of data quality and completeness. A pre-test of the data collection tool was performed on ten cases from 2022, which were excluded from the final analysis. The final data collection was conducted using smartphones equipped with the KoboCollect® application, based on a structured digital questionnaire. The process was supervised by a surgical oncologist. Data analysis Data were cleaned using Microsoft Excel 2021, and analysis was performed using RStudio (version 2024.09.0) and R (version 4.3.2). Quantitative variables were described using means and standard deviations or medians and interquartile ranges, depending on distribution. Qualitative variables were summarized using frequencies and percentages. A Kaplan-Meier survival analysis was conducted. A p value < 0.05 was considered statistically significant. Ethical considerations This study received ethical approval from the Health Sciences Research Ethics Committee (Comité d’Éthique pour la Recherche en Sciences de la Santé – CER-SS) of the University of Abomey-Calavi, Benin. It was registered under reference number 005-2025/CER-SS. Authorization from hospital administrators and unit heads was obtained prior to data collection. In addition, letters of permission were provided by all hospitals where data collection took place by the hospital administration. Strict confidentiality and professional secrecy were maintained. Completed forms were stored securely. Access to the digital database was restricted to the research team, protected by username and password. Files were anonymized and coded before any electronic transfer. Results Surgical oncology case load Between January 1 and December 31, 2023, a total of 7,902 surgical procedures were performed across the three hospitals. Of these, 155 were cancer-related, representing 1.96% of the overall surgical volume. Sociodemographic and clinical characteristics Among the 155 patients included, most were women (52.9%), yielding a sex ratio of 0.9. The mean age was 54.3 years (SD 17.5; range 4–84), with the most represented age groups being 51–60 years (26.8%) and 61–70 years (25.5%) (Fig. 2). Nearly one-fifth of patients were in senior management positions (20.6%), while 6.5% were manual workers. The majority (61.3%) were admitted through post-consultation surgical programs, and only 5.8% underwent emergency procedures. Hypertension (28.3%) and diabetes (8.9%) were the most frequent comorbidities, whereas 63.7% had none. At the time of surgery, most cancers were advanced: 71.6% were stage III–IV, with stage III (30.3%) and stage IV (23.2%) representing more than half of the cases. Details on the stage distribution of cancers by type at the time of surgery are provided in Supplementary Table S2. Few patients had received prior treatment before surgery, mainly chemotherapy (21.3%). Preoperative histological confirmation was documented in 48.4% of cases. Table 1 summarizes the sociodemographic and clinical profile of patients who underwent cancer-related surgery. Fig. 2Age distribution of patients undergoing cancer surgery in tertiary hospitals of the Littoral Department, 2023 Age distribution of patients undergoing cancer surgery in tertiary hospitals of the Littoral Department, 2023 Table 1Sociodemographic and clinical profile of patients undergoing surgical oncology procedures in the Littoral Department, Benin (2023)Number (n)Proportion (%)Occupation (n = 155) Senior management3220.6 Shopkeeper2415.5 Craftsperson1912.3 Middle manager1912.3 Manual worker1006.5 Student0603.9 Fisherman/Farmer0301.9 Not specified4227.1Mode of patient admission (n = 155) Post-consultation surgical program9561.3 Emergency905.8 Transfer/Referral from another center905.8 Other4227.1Comorbidities * Diabetes1008.9 Hypertension3228.3 HIV0201.8 Hepatitis0100.9 Other comorbidity1209.7 No comorbidity7263.7Cancer stage (N = 155) I0704.5 II2616.8 III4730.3 IV3623.2 Not specified3925.2Type of treatment received before surgery (N = 51) Chemotherapy3376.7 Surgery1534.9 Radiotherapy0204.7 Hormone therapy0102.3Preoperative histology Yes7548.4 No3623.2 Not specified4428.4*Multiple responses were possible, percentages therefore may not sum to 100% Table 1Sociodemographic and clinical profile of patients undergoing surgical oncology procedures in the Littoral Department, Benin (2023)Number (n)Proportion (%)Occupation (n = 155) Senior management3220.6 Shopkeeper2415.5 Craftsperson1912.3 Middle manager1912.3 Manual worker1006.5 Student0603.9 Fisherman/Farmer0301.9 Not specified4227.1Mode of patient admission (n = 155) Post-consultation surgical program9561.3 Emergency905.8 Transfer/Referral from another center905.8 Other4227.1Comorbidities * Diabetes1008.9 Hypertension3228.3 HIV0201.8 Hepatitis0100.9 Other comorbidity1209.7 No comorbidity7263.7Cancer stage (N = 155) I0704.5 II2616.8 III4730.3 IV3623.2 Not specified3925.2Type of treatment received before surgery (N = 51) Chemotherapy3376.7 Surgery1534.9 Radiotherapy0204.7 Hormone therapy0102.3Preoperative histology Yes7548.4 No3623.2 Not specified4428.4*Multiple responses were possible, percentages therefore may not sum to 100% Sociodemographic and clinical profile of patients undergoing surgical oncology procedures in the Littoral Department, Benin (2023) *Multiple responses were possible, percentages therefore may not sum to 100% Distribution of surgical procedures Most procedures were performed at CNHU-HKM (39.5%), followed by CHU-MEL (37.7%) and CHUZ Suru-Léré (22.8%). Visceral/general surgery accounted for the largest share (56.8%), followed by urology-andrology (19.4%) and gynecology-obstetrics (18.1%). Pediatric surgery (3.2%), ENT–head and neck surgery (1.9%), and neurosurgery (0.7%) accounted for smaller shares of cancer-related procedures. By intent, 43.9% of procedures were curative, 38.1% palliative, and 17.4% diagnostic. Breast cancer was the most frequent indication (n = 36), followed by prostate (n = 24), stomach (n = 16), colon (n = 16), and rectum (n = 10). Table 2 presents the distribution of major cancer sites by surgical intent. Table 2Most Common Cancer Site by Surgical Intent*Cancer SiteTotal, NoDiagnosis, No.(%)Curative, No. (%)Palliative, No. (%)Reconstruction, No. (%)All sites15527 (17.4)68 (43.9)59 (38.1)1 (0.7)Breast364 (11.1)20 (55.6)12 (33.3)0 (0.0)Cervix80 (0.0)6 (75.0)2 (25.0)0 (0.0)Colon162 (12.5)11 (68.8)2 (12.5)1 (6.2)Uterus31 (33.3)1 (33.3)1 (33.3)0 (0.0)Stomach162 (12.5)4 (25.0)10 (62.5)0 (0.0)Liver11 (100.0)0 (0.0)0 (0.0)0 (0.0)Small intestine21 (50.0)1 (50.0)0 (0.0)0 (0.0)Abdominal esophagus10 (0.0)0 (0.0)1 (100.0)0 (0.0)Bones20 (0.0)2 (100.0)0 (0.0)0 (0.0)Ovary53 (60.0)2 (40.0)0 (0.0)0 (0.0)Pancreas73 (42.8)1 (14.3)3 (42.8)0 (0.0)Parotid gland10 (0.0)1 (100.0)0 (0.0)0 (0.0)Skin30 (0.0)3 (100.0)0 (0.0)0 (0.0)Prostate242 (8.3)3 (12.5)19 (79.2)0 (0.0)Rectum102 (20.0)2 (20.0)6 (60.0)0 (0.0)Kidney20 (0.0)2 (100.0)0 (0.0)0 (0.0)Sinus11 (100.0)0 (0.0)0 (0.0)0 (0.0)Central nervous system10 (0.0)0 (0.0)1 (100.0)0 (0.0)Thyroid10 (0.0)0 (0.0)1 (100.0)0 (0.0)Soft tissues71 (14.3)5 (71.4)1 (14.3)0 (0.0)Gallbladder20 (0.0)2 (100.0)0 (0.0)0 (0.0)Bladder53 (60.0)2 (40.0)0 (0.0)0 (0.0)Upper respiratory tract11 (100.0)0 (0.0)0 (0.0)0 (0.0)*Multiple responses were possible, percentages therefore may not sum to 100% Table 2Most Common Cancer Site by Surgical Intent*Cancer SiteTotal, NoDiagnosis, No.(%)Curative, No. (%)Palliative, No. (%)Reconstruction, No. (%)All sites15527 (17.4)68 (43.9)59 (38.1)1 (0.7)Breast364 (11.1)20 (55.6)12 (33.3)0 (0.0)Cervix80 (0.0)6 (75.0)2 (25.0)0 (0.0)Colon162 (12.5)11 (68.8)2 (12.5)1 (6.2)Uterus31 (33.3)1 (33.3)1 (33.3)0 (0.0)Stomach162 (12.5)4 (25.0)10 (62.5)0 (0.0)Liver11 (100.0)0 (0.0)0 (0.0)0 (0.0)Small intestine21 (50.0)1 (50.0)0 (0.0)0 (0.0)Abdominal esophagus10 (0.0)0 (0.0)1 (100.0)0 (0.0)Bones20 (0.0)2 (100.0)0 (0.0)0 (0.0)Ovary53 (60.0)2 (40.0)0 (0.0)0 (0.0)Pancreas73 (42.8)1 (14.3)3 (42.8)0 (0.0)Parotid gland10 (0.0)1 (100.0)0 (0.0)0 (0.0)Skin30 (0.0)3 (100.0)0 (0.0)0 (0.0)Prostate242 (8.3)3 (12.5)19 (79.2)0 (0.0)Rectum102 (20.0)2 (20.0)6 (60.0)0 (0.0)Kidney20 (0.0)2 (100.0)0 (0.0)0 (0.0)Sinus11 (100.0)0 (0.0)0 (0.0)0 (0.0)Central nervous system10 (0.0)0 (0.0)1 (100.0)0 (0.0)Thyroid10 (0.0)0 (0.0)1 (100.0)0 (0.0)Soft tissues71 (14.3)5 (71.4)1 (14.3)0 (0.0)Gallbladder20 (0.0)2 (100.0)0 (0.0)0 (0.0)Bladder53 (60.0)2 (40.0)0 (0.0)0 (0.0)Upper respiratory tract11 (100.0)0 (0.0)0 (0.0)0 (0.0)*Multiple responses were possible, percentages therefore may not sum to 100% Most Common Cancer Site by Surgical Intent* *Multiple responses were possible, percentages therefore may not sum to 100% Types of procedures and operational characteristics Radical mastectomy was the most frequent operation (n = 28; 18.1%), followed by prostate drilling (n = 18; 11.6%) and colectomy (n = 11; 7.1%). Other common procedures included colostomy (5.2%), limb amputation (3.9%), colpohysterectomy (3.9%), and gastrectomy (3.2%). A detailed breakdown is provided in Table 3. Table 3Most Common Oncologic Procedures *NumberProportion (%)Radical mastectomy2818.1Channeling Transurethral Resection of the Prostate1811.6Colectomy/ Cecum resection117.1Colostomy085.2Limb amputation063.9Colpohysterectomy063.9Gastrectomy053.2Feeding jejunostomy053.2Transurethral resection of the bladder053.2Cholecystectomy042.6Partial mastectomy/ lumpectomy042.6Total hysterectomy031.9Feeding gastrostomy021.3Abdominal wall tumor resection021.3Pancreaticoduodenectomy021.3Biliary and digestive diversions021.3Oophorectomy/ Adnexectomy042.6Other4025.8Multiple responses were possible, percentages therefore may not sum to 100% Table 3Most Common Oncologic Procedures *NumberProportion (%)Radical mastectomy2818.1Channeling Transurethral Resection of the Prostate1811.6Colectomy/ Cecum resection117.1Colostomy085.2Limb amputation063.9Colpohysterectomy063.9Gastrectomy053.2Feeding jejunostomy053.2Transurethral resection of the bladder053.2Cholecystectomy042.6Partial mastectomy/ lumpectomy042.6Total hysterectomy031.9Feeding gastrostomy021.3Abdominal wall tumor resection021.3Pancreaticoduodenectomy021.3Biliary and digestive diversions021.3Oophorectomy/ Adnexectomy042.6Other4025.8Multiple responses were possible, percentages therefore may not sum to 100% Most Common Oncologic Procedures * Multiple responses were possible, percentages therefore may not sum to 100% Surgical approach and postoperative outcomes Open surgery predominated (80.6%), while minimally invasive procedures accounted for 19.4%. Lymph node dissection was performed in 31.6% of cases. Postoperative complications occurred in 19.7% of patients, most commonly hemorrhage (26.1% of complications), wound infection (21.7%), and shock (17.4%). Of the medical records reviewed, 114 contained follow-up data suitable for survival analysis. At 30 days, 65.8% of patients were alive, 28.1% were lost to follow-up, and 6.1% had died. The causes of death among the seven patients who died were septic shock (n = 2), severe anemia (n = 1), and respiratory distress (n = 1). Surgical characteristics and postoperative outcomes are summarized in Table 4. Table 4Surgical characteristics and postoperative outcomesNumberProportion (%)Lymph node dissection (n = 155) Yes4931.6 No8252.9 Not specified2415.5Grade of the main surgeon (n = 155) Resident1811.6 Specialist Hospital Practitioner5837.4 Academic Hospital Practitioner7951.0Resection/ margins (n = 155) R03019.4 R1074.5 R2095.8 Not specified10970.3Postoperative complications (n = 117) Yes2319.7 No9480.3Types of complications (n = 15) Hemorrhage626.1 Surgical site infection521.7 Shock417.430-day postoperative outcome (n = 114) Alive7565.8 Lost to follow-up3228.1 Deceased76.14Cause of death (n = 7) Septic shock228.6 Severe anemia114.3 Dyspnea114.3 Table 4Surgical characteristics and postoperative outcomesNumberProportion (%)Lymph node dissection (n = 155) Yes4931.6 No8252.9 Not specified2415.5Grade of the main surgeon (n = 155) Resident1811.6 Specialist Hospital Practitioner5837.4 Academic Hospital Practitioner7951.0Resection/ margins (n = 155) R03019.4 R1074.5 R2095.8 Not specified10970.3Postoperative complications (n = 117) Yes2319.7 No9480.3Types of complications (n = 15) Hemorrhage626.1 Surgical site infection521.7 Shock417.430-day postoperative outcome (n = 114) Alive7565.8 Lost to follow-up3228.1 Deceased76.14Cause of death (n = 7) Septic shock228.6 Severe anemia114.3 Dyspnea114.3 Surgical characteristics and postoperative outcomes Survival analysis Survival analysis was possible for 111 patients with complete data. The Kaplan–Meier estimate showed a 30-day survival probability of 94% (95% CI: 89–99%), as illustrated in Fig. 3. Fig. 3Kaplan–Meier survival curve for the first 30 days after surgery (n = 111) Kaplan–Meier survival curve for the first 30 days after surgery (n = 111) Discussion In this study, cancer surgery represented less than 2% of the overall surgical workload in tertiary hospitals in Benin, a proportion considerably lower than the 6.4% reported in Tanzania [2] but comparable to data from Ghana (< 2%) [13]. These findings highlight both the limited scale of surgical oncology services in Benin and the structural barriers constraining access to care. Profile of the included hospitals and their role in cancer control The three tertiary hospitals included in this study are all recognized in the first National Cancer Control Plan (PNLC 2013–2017) [14] of Benin as referral centers for cancer diagnosis and management. The CNHU–HKM serves as the national referral center for complex pathologies, including cancer, since its creation. The CHU–MEL is the national reference center for women’s and children’s health, with a specific focus on female cancers. The CHUZ of Suru-Léré, recently upgraded from a departmental to a university hospital, currently lacks specialized oncology services (see Supplementary Table S1). Two of these hospitals host dedicated oncology activities (surgical or medical), while the third contributes primarily to diagnostic and general surgical care. Patient profile and clinical implications The median age of 56 years was consistent with previous reports from Tanzania [2] and other sub-Saharan African series, underscoring that cancer disproportionately affects adults during their most economically productive years. This burden extends beyond the individual, as illustrated by the high proportion of breast cancer deaths in women under 50, often leaving young children maternally orphaned [15]. In sub-Saharan Africa, nearly 50% of breast cancer deaths occur in women under 50 years of age, leaving on average 210 children maternally orphaned for every 100 deaths in this age group [15]. Comorbidities, particularly hypertension and diabetes, were common, reflecting the ongoing epidemiological transition in LMICs. These conditions add perioperative risk and highlight the importance of preoperative optimization protocols tailored to resource-limited settings. Cancer distribution and stage at presentation Breast cancer was the most frequently operated malignancy (23.2%), consistent with global patterns [1]. However, the predominance of radical mastectomy is concerning, as surgical management of breast cancer has shifted worldwide toward de-escalation. In Benin, this trend is explained by two factors: late presentation with locally advanced disease and the absence of radiotherapy, which precludes breast-conserving strategies [9]. These findings underscore the urgent need to strengthen targeted early detection programs for breast cancer in sub-Saharan Africa, through community-based strategies and enhanced training of frontline health workers, while also improving access to comprehensive oncologic care. Given that 76.7% of patients received chemotherapy before their oncologic surgery, the clinical stage at the time of surgery may not fully reflect their initial disease extent. This treatment-related downstaging represents an important limitation when interpreting stage distribution in our cohort. Overall, more than 50% of cancers were managed at advanced stages (III–IV), a pattern repeatedly documented across sub-Saharan Africa [2, 13]. The lack of organized screening, low public awareness, and delayed access to specialized facilities severely limit opportunities for curative intervention. Surgical practice and technology gaps Carcinomas predominated histologically, leading to frequent lymph node dissections, most often axillary. Sentinel lymph node biopsy is not yet available in Benin because of three barriers: advanced presentation with clinically overt nodal disease, the absence of nuclear medicine services, and the lack of surgeon training in this technique. As a result, patients are subjected to more invasive procedures, with potential consequences for morbidity and quality of life. The presence of nephroblastomas in children; although rare (1.98% of oncologic surgeries), underscores the unmet need for pediatric surgical oncology, in line with the WHO Global Initiative for Childhood Cancer (GICC), which aims to achieve at least 60% survival by 2030 [16]. In sub-Saharan Africa, survival remains far lower due to late diagnosis, treatment abandonment, and limited access to multidisciplinary care [17]. Surgical intent and outcomes Although the present study did not assess the availability of multidisciplinary team meetings (MDTMs), recent national data show that only a minority of public hospitals in Benin (16%) currently organize them [18], mostly in university-affiliated institutions. The absence of regular MDTMs represents a major challenge for ensuring coordinated care and evidence-based decision-making in cancer management. Of all procedures, 43.9% were reported as curative, 17.4% as diagnostic, and 38.1% as palliative, closely mirroring the distribution reported by Brand et al. in Tanzania (42%, 25%, and 27%, respectively) [2]. Although most operations were recorded as curative, this proportion probably overestimates the actual rate of curative treatment. In Benin, as in many sub-Saharan African settings, cancers are predominantly diagnosed at advanced stages, and adjuvant treatments remain scarce or inaccessible for most patients. Consequently, many surgeries classified as curative may have actually been performed in a palliative or cytoreductive intent rather than with a realistic expectation of cure. In this study, the relatively high proportion of diagnostic surgery reflects the lack of interventional radiology and limited availability of advanced imaging such as PET-CT. Palliative interventions, frequently required to manage obstruction, bleeding, or intractable pain, continue to represent a central component of care for advanced cancers. Thirty-day mortality was 6.1%, broadly comparable to other reports from the region [2]. However, nearly one-third of patients were lost to follow-up, illustrating major challenges for perioperative surveillance and outcome measurement. Implications for policy and practice Our findings highlight three priority actions for Benin. First, strengthening early diagnosis through structured screening programs and community awareness initiatives is essential, particularly given the high burden of advanced cancers in LMICs and their impact on surgical outcomes, as emphasized by Kivuyo et al. [19]. In low- and middle-income countries such as Benin, efforts to strengthen cancer control should prioritize early diagnosis and screening for the most frequent and surgically treatable cancers, including breast, cervical, and colorectal cancers. Second, building a solid foundation for surgical oncology requires ensuring access to safe anesthesia, adequate surgical equipment, and postoperative care, while reinforcing training for general surgeons in essential cancer procedures. Advanced techniques such as minimally invasive surgery and interventional radiology can be progressively integrated as capacity and infrastructure improve. Emerging specialization and subspecialization programs in West Africa, under the auspices of the West African College of Surgeons (WACS) and Cheikh Anta Diop University of Dakar (UCAD), are providing promising opportunities for capacity building in surgical oncology [20, 21]. Third, because sustained governmental commitment and adequate financial investment are the cornerstone for developing and maintaining oncology services in such contexts, these advances should be integrated into structured multidisciplinary care pathways and embedded in the forthcoming second edition of the National Cancer Control Plan, backed by consistent political will and financial support. A further promising step would be the formal recognition of surgical oncology as a distinct subspecialty in sub-Saharan Africa, and in Benin in particular, acknowledging that it is both a cognitive and technical discipline whose added value to multidisciplinary cancer care lies in its specialized expertise across prevention, diagnosis, treatment, and rehabilitation [22]. However, while subspecialty training in surgical oncology is essential for improving the quality and comprehensiveness of care, it should not be viewed as a prerequisite for the introduction or expansion of cancer surgery programs in resource-limited settings. The study has several limitations. First, it was retrospective and limited to three tertiary hospitals in one urban region, which may not fully represent national surgical oncology activity. Second, data completeness depended on the accuracy of hospital records, and some variables (e.g., stage, type of complication) were occasionally missing. Third, postoperative follow-up was limited to 30 days, preventing longer-term outcome assessment. Despite these limitations, this multicenter study provides one of the first comprehensive overviews of cancer surgery activity in Benin and may serve as a benchmark for capacity planning in similar low-resource settings. Conclusion Surgical volume is a critical indicator for surgeon training, hospital accreditation, and institutional certification. This study provides the first quantification of the contribution of surgical oncology to the overall surgical workload in tertiary hospitals in the Littoral Department of Benin. Surgical oncology represented a small yet essential component of surgical activity. In 2023, oncologic surgeries accounted for only a modest proportion of total procedures, and most operated cancers were advanced-stage tumours. Improving timely referral pathways and optimizing perioperative care could help enhance surgical outcomes and, even modestly, contribute to reducing cancer-related mortality, which remains among the highest in the sub-Saharan Africa region. Supplementary Information Supplementary Material 1. Supplementary Material 1.